Dr. Kipp Weiskopf is a Valhalla Fellow at the Whitehead Institute. Dr. Weiskopf’s lab studies novel macrophage and myeloid immune checkpoints. Weiskopf began studying the CD47/SIRP⍺ interaction as a graduate...
|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
Sunday
|
|---|---|---|---|---|---|---|
|
0 events,
|
1 event,
Dr. Kipp Weiskopf is a Valhalla Fellow at the Whitehead Institute. Dr. Weiskopf’s lab studies novel macrophage and myeloid immune checkpoints. Weiskopf began studying the CD47/SIRP⍺ interaction as a graduate... |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
1 event,
Dr. Roslyn Kemp is a Professor of Immunology at the University of Otago. Dr. Kemp’s research focuses on T cells as mediators of anti-tumour immunity and inflammation. Specifically, they study... |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|